[1] Weibel E K, Hadvary P, Hochuli E, et al. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity[J]. J Antibiot, 1987, 40(8): 1 081-1 085.
[2] Hochuli E, Kupfer E, Maurer R, et al. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini.Ⅱ. Chemistry and Structure elucidation[J]. J Antibiot, 1987, 40: 1 086-1 091.
[3] Yang Xiao-bo(杨小波),Chen Zai-xin(陈再新),Zhang Yi-hua(张奕华). Progress in total synthesis of orlistat(奥利司他的全合成研究进展)[J]. Chinese J Org Chem(有机化学),2005, 25(8): 902-912.
[4] Yin J, Yang X B, Chen Z X, et al. Total synthesis of (-)tetrahydrolipstatin by the tandem mukaiyama-aldol lactonization[J]. Chinese Chem Lett, 2005, 16(11): 1 448-1 450.
[5] Andrej Dolenc, Biljana Govedarica, Rok Dreu, et al. Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition[J]. Int J Pharm, 2010, 396(1-2): 149-155.
[6] Aneta Novotna, Aneta Doricakova, Radim Vrzal, et al. Investigation of orlistat effects on PXR activation and CYP3A4 expression in primary human hepatocytes and human intestinal LS174T cells[J]. Eur J Pharma Sci, 2010, 49(2): 276-280.
[7] Mohammadi A, Haririan I, Rezanour N, et al. A stability-indicating high performance liquid chromatographic assay for the determination oforlistat in capsules[J]. J Chromatogr A, 2006, 1 116(1-2): 153-157.
[8] Tronco A L S, Barroso S G, Rodrigues M L G, et al. The effects of orlistat on the metabolic profile of obese patients[J]. American Journal of Hypertension, 2001, 14(1): 583-584.
[9] Agnes P, Jean M P. An Asymmetric synthesis of (-) -Tetrahydrolipstatin[J]. Synthesis, 1994, (12): 1 294-1 300.
[10] Ian F, Nicholas J L. Stereocontrol in organic synthesis using siliconcontaining compounds. A synthesis of (-)-tetrahydrolipstatin using the alkylation of a β-silyl ester and the hydroboration of an allysilane[J]. J Chem Soc Perk T1, 1998: 2 679-2 686.
[11] Ning Yong-cheng(宁永成). Structural Identification of Organic Compounds and Organic Spectroscopy(有机化合物结构鉴定与有机波谱学)[M]. Bejing(北京): Scinence Press(科学出版社), 2000.
[12] Zhao Tian-zeng(赵天增). Proton NMR Spectroscopy(核磁共振图谱)[M]. Beijing(北京): Peking University Press(北京大学出版社), 1982.
[13] Huang Lu(黄璐), Sun Hua-jun(孙华君), Yang Bo(杨波), et al. Spectral Analysis and structural elucidation of clevidipine butyrate(丁酸氯维地平的波谱学数据与结构确证)[J]. Chinese J Magn Reson(波谱学杂志), 2011, 28(1): 168-175.
[14] Zhang Zhi(张志), Mao Wei-ping(毛卫平), Liu Chao-yang(刘朝阳). Progress in the development of pulse programmer for nuclear magnetic resonance(核磁共振脉冲序列发生器研究进展)[J]. Chinese J Magn Reson(波谱学杂志), 2012, 29(3): 339-345. |